EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

The Signature of Serum Modified Nucleosides in Uveitis

Haoze Zhou, Yiqiu Hu, Guangming Qin, Jinfeng Kong, Xiujuan Hong, Cheng Guo, Jian Zou, Lei Feng

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.2.68 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Haoze Zhou and 7 co-authors. Institution: Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Major MEDLINE topics: Uveitis, Nucleosides. Cited 3 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

This study aims to evaluate the metabolism of serum-modified nucleosides in uveitis by using liquid chromatography-tandem mass spectrometry (LC-MS) and to develop potential diagnostic biomarkers for uveitis.

Methods

Forty-two patients with different subtypes of uveitis (idiopathic uveitis, Vogt-Koyanagi-Harada [VKH] disease, and ankylosing spondylitis [AS]) and 32 healthy controls were recruited in this retrospective case-control study. The concentrations of 23 modified nucleosides in patient serum were quantified by LC-MS. The data was statistically analyzed with SPSS and GraphPad Prism.

Results

The data revealed that 13 out of 23 modified nucleosides (m6A, m1A, m6Am, Cm, ac4C, Gm, m1G, m2G, m2,2G, Um, m3U, m5U, and m5Um) effectively showed quantifiable chromatographic peaks. The statistical results indicated that there were extremely significant differences for m2G, Gm, Cm, and m1G between healthy controls and uveitis patients. The differences for Gm, m6A,and m5U were able to further assort idiopathic uveitis and uveitis with systemic inflammation including VKH and AS. Interestingly, each specific subtype of uveitis is characterized by its signature combination of serum-modified nucleotides comparing with healthy controls.

Conclusions

This study revealed that the metabolism of serum-modified nucleosides in uveitis patients display significant differences from healthy controls. The signature combination of serum modified nucleotides for each subtype of uveitis may be applied for the potential diagnosis of uveitis.

Subjects

MeSH terms (MEDLINE)

UveitisNucleosidesHumansMaleFemaleRetrospective StudiesAdultBiomarkersCase-Control StudiesMiddle AgedChromatography, LiquidTandem Mass SpectrometryYoung AdultUveomeningoencephalitic SyndromeAged

Substances

NucleosidesBiomarkers

Authors and institutions

  • Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Institute of Genetics, Zhejiang University International School of Medicine, Hangzhou, China.

Cite

APA

Zhou, H., Hu, Y., Qin, G., Kong, J., Hong, X., Guo, C., Zou, J., & Feng, L. (2025). The Signature of Serum Modified Nucleosides in Uveitis. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.68

Vancouver

Zhou H, Hu Y, Qin G, Kong J, Hong X, Guo C, et al. The Signature of Serum Modified Nucleosides in Uveitis. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.68

BibTeX
@article{Zhou2025,
  author = {Zhou, Haoze and Hu, Yiqiu and Qin, Guangming and Kong, Jinfeng and Hong, Xiujuan and Guo, Cheng and Zou, Jian and Feng, Lei},
  title = {The Signature of Serum Modified Nucleosides in Uveitis},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.2.68}
}
Start for free →